John Tole, DO
Allergy · Birmingham, ALNPI 1568671584
Payments from drug & device makers
Across 776 payments — averaging $86.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Consortium Of Independent Immunology Clinics, LLC$42K
- AstraZeneca$6K
- Novartis$4K
- Takeda Pharmaceuticals U.S.A., Inc.$4K
- GSK$2K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $8K from 30 others
Across 1 payment — averaging $1750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Consortium Of Independent Immunology Clinics, LLC$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Consortium Of Independent Immunology Clinics, LLC | 8 | $42,127 |
| AstraZeneca(2 entities) | 174 | $5,621 |
| Novartis | 28 | $4,007 |
| Takeda Pharmaceuticals U.S.A., Inc. | 43 | $3,865 |
| GSK | 94 | $2,070 |
| Regeneron Healthcare Solutions, Inc. | 60 | $1,569 |
| CSL Behring | 45 | $1,271 |
| Pfizer | 60 | $1,112 |
| Grifols USA, LLC | 51 | $1,070 |
| Genentech USA, Inc. | 47 | $1,017 |
| Sanofi | 25 | $869 |
| Octapharma USA, Inc. | 21 | $507 |
| Teva Pharmaceuticals USA, Inc. | 37 | $378 |
| Pharming Healthcare, Inc. | 9 | $291 |
| ADMA Biomanufacturing LLC | 3 | $235 |
| Amgen | 13 | $233 |
| Blueprint Medicines Corporation | 9 | $195 |
| Biocryst US Sales Co., LLC | 8 | $153 |
| Kaleo, Inc. | 8 | $121 |
| Galderma Laboratories, L.p. | 1 | $93 |
| LEO Pharma Inc. | 5 | $87 |
| GC Biopharma USA, Inc. | 4 | $87 |
| Hikma Pharmaceuticals USA | 3 | $56 |
| Shire North American Group Inc | 3 | $50 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $50 |
| Cycle Pharmaceuticals Inc | 2 | $47 |
| Boehringer Ingelheim | 3 | $43 |
| Alk-abello, Inc | 2 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Kedrion Biopharma, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $18 |
| Organon | 1 | $17 |
| Merck | 1 | $16 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
| Optinose US, Inc. | 1 | $14 |
| Tersera Therapeutics LLC | 1 | $12 |
How this compares
Too few allergy providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Birmingham
- John MeadowsBirmingham$204K
- William FancherBirmingham$3K
- Joseph GiannobileBirmingham$991
- Druhan HowellMobile$201K
- Shashi KumarHuntsville$8K
- Lucinda PattonMobile$3K
- Valerie leMadison$1K
- Charles BrentnallSylacauga$1K
- Steven HelmTuscaloosa$185
- Alma HerreraMobile$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.